Action Bemis - BMS

Bemis Company, Inc. (BMS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

57,25

( - )

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

57,25

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and Other Developmental Compounds at the 66th American Society of Hematology (ASH) Annual Meeting

K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and...

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th...

Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors

MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Extension Of Exchange Offers And Consent Solicitations For US$2.2 ...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Extension Of Exchange Offers And Consent Solicitations For US$2.2 Billion Of Notes PR...

Bemis Set to Join S&P 500; Mattel to Join S&P MidCap 400

Bemis Set to Join S&P 500; Mattel to Join S&P MidCap 400 PR Newswire NEW YORK, June 3, 2019 NEW YORK, June 3, 2019 /PRNewswire/...

US Antitrust Clearance Received for Amcor and Bemis Transaction Enabling Completion on 11 June 2019

Amcor Limited (ASX: AMC) and Bemis Company, Inc. (NYSE: BMS) announce that regulatory clearance has been received from the US Department of...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Results Of Early Tenders In Exchange Offers And Consent Solicitati...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Results Of Early Tenders In Exchange Offers And Consent Solicitations For US$2.2...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Exchange Offers And Consent Solicitations For US$2.2 Billion Of No...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Exchange Offers And Consent Solicitations For US$2.2 Billion Of Notes PR...

Amcor and Bemis Transaction – Timetable Update

Amcor Limited (ASX: AMC) and Bemis Company, Inc. (NYSE: BMS) have made significant progress towards closing the all-stock transaction...

Bemis Shareholders Approve Combination with Amcor

Bemis Company, Inc. (NYSE: BMS) today announced that its shareholders voted to approve Bemis’ combination with Amcor Limited (ASX: AMC) at the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

BMS - Frequently Asked Questions (FAQ)

What is the current Bemis Company, Inc. share price?

The current share price of Bemis Company, Inc. is US$ 57,25

What is the 1 year trading range for Bemis Company, Inc. share price?

Bemis Company, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bemis Company, Inc. (BMS)

Bemis Company, Inc. (BMS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BMS Dernières nouvelles

K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and Other Developmental Compounds at the 66th American Society of Hematology (ASH) Annual Meeting

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Extension Of Exchange Offers And Consent Solicitations For US$2.2 ...

Bemis Set to Join S&P 500; Mattel to Join S&P MidCap 400

US Antitrust Clearance Received for Amcor and Bemis Transaction Enabling Completion on 11 June 2019

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Results Of Early Tenders In Exchange Offers And Consent Solicitati...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Exchange Offers And Consent Solicitations For US$2.2 Billion Of No...

Amcor and Bemis Transaction – Timetable Update

Bemis Shareholders Approve Combination with Amcor

BMS - Frequently Asked Questions (FAQ)

BMS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bemis Company, Inc. (BMS)

Bemis Company, Inc. (BMS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BMS Dernières nouvelles

K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and Other Developmental Compounds at the 66th American Society of Hematology (ASH) Annual Meeting

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Extension Of Exchange Offers And Consent Solicitations For US$2.2 ...

Bemis Set to Join S&P 500; Mattel to Join S&P MidCap 400

US Antitrust Clearance Received for Amcor and Bemis Transaction Enabling Completion on 11 June 2019

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Results Of Early Tenders In Exchange Offers And Consent Solicitati...

Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Exchange Offers And Consent Solicitations For US$2.2 Billion Of No...

Amcor and Bemis Transaction – Timetable Update

Bemis Shareholders Approve Combination with Amcor

BMS - Frequently Asked Questions (FAQ)

BMS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE